11th week of 2019 patent applcation highlights part 22 |
Patent application number | Title | Published |
20190077809 | Spirocyclic Derivatives | 2019-03-14 |
20190077810 | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF | 2019-03-14 |
20190077811 | Ginkgolide B Derivative and Preparation Method And Use Thereof | 2019-03-14 |
20190077812 | METHOD FOR MANUFACTURING 7alpha-ALKOXYOXACEPHEM INTERMEDIATE COMPOUND | 2019-03-14 |
20190077813 | PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE | 2019-03-14 |
20190077814 | BORON-CONTAINING SMALL MOLECULES | 2019-03-14 |
20190077815 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | 2019-03-14 |
20190077816 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLIGOMERIZING OLEFIN USING SAME | 2019-03-14 |
20190077817 | COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS | 2019-03-14 |
20190077818 | ORGANIC LUMINESCENT MATERIALS CONTAINING FLUORINE ANCILLARY LIGANDS | 2019-03-14 |
20190077819 | METAL COMPLEXES FOR DEPOSITING FILMS AND METHOD OF MAKING AND USING THE SAME | 2019-03-14 |
20190077820 | PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING CRYSTALLINE ALPHA, ALPHA-TREHALOSE DI-HYDRATE | 2019-03-14 |
20190077821 | Brain-Targeting Prodrug for AMPA Receptor Synergist, and Pharmaceutical Applications Thereof | 2019-03-14 |
20190077822 | NOVEL MANNITOL-BASED AMPHIPATHIC COMPOUND AND USE THEREOF | 2019-03-14 |
20190077823 | HIGHLY SOLUBLE STEVIOL GLYCOSIDES | 2019-03-14 |
20190077824 | N-ALKYL 2-(DISUBSTITUTED)ALKYNYLADENOSINE-5-URONAMIDES AS A2A AGONISTS | 2019-03-14 |
20190077825 | METHODS OF MODULATING KEAP1 | 2019-03-14 |
20190077826 | METHODS FOR PREPARING DEOXYCHOLIC ACID | 2019-03-14 |
20190077827 | 6.Alpha.-Alkyl-6,7-Dione Steroids as Intermediates for the Production of Steroidal FXR Modulators | 2019-03-14 |
20190077828 | HIGH PH PROTEIN REFOLDING METHODS | 2019-03-14 |
20190077829 | METHODS AND COMPOSITIONS TO INCREASE THE RATE OF LIGATION REACTIONS CATALYZED BY A SORTASE | 2019-03-14 |
20190077830 | SYSTEM AND METHOD FOR PRODUCING INTERLEUKIN RECEPTOR ANTAGONIST (IRA) | 2019-03-14 |
20190077831 | CONNECTIVE TISSUE STIMULATING PEPTIDES | 2019-03-14 |
20190077832 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2019-03-14 |
20190077833 | CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES | 2019-03-14 |
20190077834 | Compstatin Analogs With Improved Pharmacokinetic Properties | 2019-03-14 |
20190077835 | ANTIBODY CAPABLE OF BINDING TO INTRANUCLEAR PROTEIN OF INFLUENZA VIRUS, COMPOSITE, DETECTION DEVICE AND METHOD USING SAME | 2019-03-14 |
20190077836 | ANTIBODY CAPABLE OF BINDING TO INTRANUCLEAR PROTEIN OF INFLUENZA VIRUS, COMPOSITE, DETECTION DEVICE AND METHOD USING SAME | 2019-03-14 |
20190077837 | Gonorrheal MtrE Peptides and Vaccines | 2019-03-14 |
20190077838 | METHOD FOR INHIBITING, IMPROVING, OR PREVENTING AGING USING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS | 2019-03-14 |
20190077839 | EVASINS FOR USE IN THERAPY AND DIAGNOSTICS | 2019-03-14 |
20190077840 | SELECTIVE MCL-1 BINDING PEPTIDES | 2019-03-14 |
20190077841 | SYSTEM AND METHOD FOR HIGH-YIELD TRANSIENT EXPRESSION IN MAMMALIAN CELLS | 2019-03-14 |
20190077842 | Method For Producing A Recombinant Protein With Reduced Impurities | 2019-03-14 |
20190077843 | RECOMBINANT HUMAN INTERFERON-LIKE PROTEINS | 2019-03-14 |
20190077844 | GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES | 2019-03-14 |
20190077845 | METHODS OF PURIFYING COLLAGEN 7 | 2019-03-14 |
20190077846 | METHOD FOR REFINING PROTEIN INCLUDING SELF-CUTTING CASSETTE AND USE THEREOF | 2019-03-14 |
20190077847 | AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF VIRAL DISEASES | 2019-03-14 |
20190077848 | ANTIVIRAL IMMUNOTHERAPY BY MEMBRANE RECEPTOR LIGATION | 2019-03-14 |
20190077849 | NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE | 2019-03-14 |
20190077850 | PATHOGEN BINDING METHODS AND COMPOSITIONS | 2019-03-14 |
20190077851 | METHODS OF USING ANTI-ALPHA TOXIN ANTIBODY | 2019-03-14 |
20190077852 | ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS | 2019-03-14 |
20190077853 | CAMELID SINGLE-DOMAIN ANTIBODY DIRECTED AGAINST PHOSPHORYLATED TAU PROTEINS AND METHODS FOR PRODUCING CONJUGATES THEREOF | 2019-03-14 |
20190077854 | ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF | 2019-03-14 |
20190077855 | COMPOSITIONS AND METHODS FOR TARGETING ACTIVIN SIGNALING TO TREAT CANCER | 2019-03-14 |
20190077856 | METHOD OF TREATING DISEASES USING KINASE MODULATORS | 2019-03-14 |
20190077857 | METHODS RELATED TO ADALIMUMAB | 2019-03-14 |
20190077858 | NOVEL HUMAN ANTIBODY AGAINST IL-18 | 2019-03-14 |
20190077859 | INTERLEUKIN-10 RECEPTOR-2 PEPTIDES, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE THEREOF | 2019-03-14 |
20190077860 | ANTI-EPHA4 ANTIBODY | 2019-03-14 |
20190077861 | BLOCKADE OF RGMb FOR REDUCING TRANSPLANTATION-ASSOCIATED IMMUNE RESPONSES | 2019-03-14 |
20190077862 | HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) | 2019-03-14 |
20190077863 | HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) | 2019-03-14 |
20190077864 | TIGIT-BINDING AGENTS AND USES THEREOF | 2019-03-14 |
20190077865 | GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT | 2019-03-14 |
20190077866 | ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-1 AND METHODS OF USE THEREOF | 2019-03-14 |
20190077867 | ANTI-HUMAN PD-L1 HUMANIZED MONOCLONAL ANTIBODY AND APPLICATION THEREOF | 2019-03-14 |
20190077868 | METHODS OF TREATING OR PREVENTING GRAFT VERSUS HOST DISEASE | 2019-03-14 |
20190077869 | IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS | 2019-03-14 |
20190077870 | ENGINEERED TRAIL FOR CANCER THERAPY | 2019-03-14 |
20190077871 | CD20 BINDING AGENTS AND USES THEREOF | 2019-03-14 |
20190077872 | METHOD FOR ENHANCING HUMORAL IMMUNE RESPONSE | 2019-03-14 |
20190077873 | HUMANIZED ANTI-CD73 ANTIBODIES | 2019-03-14 |
20190077874 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TUBEROUS SCLEROSIS | 2019-03-14 |
20190077875 | CLINICAL ASSESSMENT OF M-PROTEIN RESPONSE IN MULTIPLE MYELOMA | 2019-03-14 |
20190077876 | NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE | 2019-03-14 |
20190077877 | GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 | 2019-03-14 |
20190077878 | METHODS FOR TREATING CANCER BY TARGETING VCAM1 AND MAEA | 2019-03-14 |
20190077879 | CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION | 2019-03-14 |
20190077880 | ANTI-HER2 ANTIBODY-DRUG CONJUGATE | 2019-03-14 |
20190077881 | MUTANT INTERLEUKIN-2 POLYPEPTIDES | 2019-03-14 |
20190077882 | ANTIBODIES TO TICAGRELOR AND METHODS OF USE | 2019-03-14 |
20190077883 | ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING | 2019-03-14 |
20190077884 | MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE | 2019-03-14 |
20190077885 | CELLULOSE ACETATE | 2019-03-14 |
20190077886 | HOMOGENEOUS POLYSACCHARIDE WITH IMMUNOREGULATION ACTIVITY AND PREPARATION METHOD THEREOF | 2019-03-14 |
20190077887 | DIENE ELASTOMER HAVING A FUNCTION IN THE MIDDLE OF THE CHAIN AND RUBBER COMPOSITION CONTAINING THE SAME | 2019-03-14 |
20190077888 | METHOD FOR PRODUCING OLIGOMER AND CATALYST | 2019-03-14 |
20190077889 | TREATMENT OF EPOXIDIZED UNSATURATED ISOOLEFIN COPOLYMERS | 2019-03-14 |
20190077890 | POLYMER BACKBONE ELEMENT TAGS | 2019-03-14 |
20190077891 | METHOD FOR MANUFACTURING MODIFIED POLYMER, MODIFIED POLYMER, RUBBER COMPOSITION AND TIRE | 2019-03-14 |
20190077892 | POLYETHYLENE RESIN COMPOSITION FOR INJECTION-MOLDING | 2019-03-14 |
20190077893 | CROSS-COPOLYMER AND MEDICAL SINGLE-LAYER TUBE INCLUDING SAME | 2019-03-14 |
20190077894 | PROCESS FOR PREPARING CATALYSTS | 2019-03-14 |
20190077895 | WASHING- AND CLEANING-ACTIVE POLYMER FILMS, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF | 2019-03-14 |
20190077896 | METHOD FOR PRODUCING CARBOXYL-GROUP-CONTAINING POLYMER COMPOSITION | 2019-03-14 |
20190077897 | BIOCOMPATIBLE DENDRONISED POLYMER AS A NON-VIRAL TRANSFECTION AGENT | 2019-03-14 |
20190077898 | MACROMONOMER COPOLYMER AND METHOD FOR PRODUCING SAME | 2019-03-14 |
20190077899 | NONCOVALENT SOFT ELASTOMER AND METHOD FOR MANUFACTURING THE SAME | 2019-03-14 |
20190077900 | METHOD FOR SYNTHESIZING A THERMOPLASTIC ELASTOMER COMPRISING AT LEAST ONE POLY(ALPHA-METHYLSTYRENE) BLOCK | 2019-03-14 |
20190077901 | NOVOLAC-TYPE PHENOLIC HYDROXY GROUP-CONTAINING RESIN, AND RESIST FILM | 2019-03-14 |
20190077902 | AQUEOUS POLYURETHANE DISPERSION | 2019-03-14 |
20190077903 | FLUOROCHEMICAL COMPOSITIONS AND METHODS | 2019-03-14 |
20190077904 | Curable Composition | 2019-03-14 |
20190077905 | EPOXY RESIN SYSTEMS | 2019-03-14 |
20190077906 | PROCESS FOR PREPARING EPOXY RESINS | 2019-03-14 |
20190077907 | POLYMERS AND COMPOUNDS BASED ON DIPYRROLO[1,2-B:1',2'-G][2,6]NAPHTHYRIDINE-5,11-DIONE | 2019-03-14 |
20190077908 | POLYESTER RESIN HAVING EXCELLENT HEAT RESISTANCE AND SOLUBILITY IN SOLVENTS, AND COATING COMPOSITION CONTAINING SAME | 2019-03-14 |